NSE BSE
krebs biochemicals & ind stock

KREBS BIOCHEMICALS & IND Share Price

- - (%)
- NSE: KREBSBIO

KREBS BIOCHEMICALS & IND Share Price Update

As of the latest trading session, KREBS BIOCHEMICALS & IND share price is currently at 99.48, which is up by 14.41 from its previous closing. Today, the stock has fluctuated between 84.42 and 102.00. Over the past year, KREBS BIOCHEMICALS & IND has achieved a return of 17.51 %. In the last month alone, the return has been 17.61 %. Read More...

KREBS BIOCHEMICALS & IND Performance

Day Range

Low84.42 High102.00
99.50

52 Week Range

Low 60.35 High 102.00
99.50

KREBS BIOCHEMICALS & IND Share Price

1937

524518

KREBSBIO

img img img img
No Data Available

Open Price

86.35

Prev. Close

85.07

Volume (Shares)

280464.00

Total traded value

279.06

Upper Circuit

102.08

Lower Circuit

68.05

Note: The current prices & values are delayed, Login to your account for live updates.

KREBS BIOCHEMICALS & IND Fundamentals


(Standalone)

Market Cap (Cr) 183.40
PE Ratio (TTM) 0.00
Book Value / Share -55.29
Beta 0.80
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -5.85

KREBS BIOCHEMICALS & IND Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 11.97
Operating Expense 18.03
Net Profit -5.85
Net Profit Margin (%) -48.87
Earnings Per Share (EPS) -2.72
EBITDA -2.91
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 12.98
Operating Expense 17.99
Net Profit -4.98
Net Profit Margin (%) -38.36
Earnings Per Share (EPS) -2.31
EBITDA -2.06
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 14.89
Operating Expense 18.63
Net Profit -3.57
Net Profit Margin (%) -23.97
Earnings Per Share (EPS) -1.66
EBITDA -0.73
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 10.58
Operating Expense 15.95
Net Profit -5.33
Net Profit Margin (%) -50.37
Earnings Per Share (EPS) -2.47
EBITDA -2.58
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 11.46
Operating Expense 18.60
Net Profit -6.94
Net Profit Margin (%) -60.55
Earnings Per Share (EPS) -3.07
EBITDA -4.43
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 50.42
Operating Expense 70.60
Net Profit -19.73
Net Profit Margin (%) -39.13
Earnings Per Share (EPS) -9.16
EBITDA -8.27
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 52.13
Operating Expense 77.44
Net Profit -24.69
Net Profit Margin (%) -47.36
Earnings Per Share (EPS) -11.30
EBITDA -15.16
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 59.70
Operating Expense 105.38
Net Profit -44.53
Net Profit Margin (%) -74.58
Earnings Per Share (EPS) -20.81
EBITDA -32.84
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 38.61
Operating Expense 82.68
Net Profit -28.36
Net Profit Margin (%) -73.45
Earnings Per Share (EPS) -14.37
EBITDA -16.95
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 23.58
Operating Expense 62.65
Net Profit -28.87
Net Profit Margin (%) -122.43
Earnings Per Share (EPS) -17.90
EBITDA -18.26
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -46.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -29.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share -34.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.23
EBITDA Margin -55.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share -23.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -31.56
Particulars MAR 2020 (Values in Cr)
Book Value / Share -13.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -54.44
Particulars MAR 2019 (Values in Cr)
Book Value / Share -8.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -19.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 174.98
Total Liabilities 174.98
Total Equity -99.46
Share Outstanding 21560000
Price to Book Ratio -1.22
Return on Assets (%) -14.11
Return on Capital (%) -29.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 189.80
Total Liabilities 189.80
Total Equity -75.09
Share Outstanding 21560000
Price to Book Ratio -4.12
Return on Assets (%) -23.45
Return on Capital (%) -65.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 159.22
Total Liabilities 159.22
Total Equity -42.73
Share Outstanding 19620000
Price to Book Ratio -3.72
Return on Assets (%) -17.81
Return on Capital (%) -41.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 133.80
Total Liabilities 133.80
Total Equity -24.99
Share Outstanding 18000000
Price to Book Ratio -5.90
Return on Assets (%) -21.57
Return on Capital (%) -71.27
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 17.31
Total Assets 142.36
Total Liabilities 142.36
Total Equity -14.28
Share Outstanding 16630000
Price to Book Ratio -13.50
Return on Assets (%) -14.05
Return on Capital (%) -55.68
Particulars MAR 2023 (Values in Cr)
Net Income -24.69
Cash from Operations -24.71
Cash from Investing -12.64
Cash from Financing 37.34
Net change in Cash -0.01
Free Cash Flow -9.55
Particulars MAR 2022 (Values in Cr)
Net Income -44.52
Cash from Operations -17.21
Cash from Investing -22.89
Cash from Financing 39.50
Net change in Cash -0.61
Free Cash Flow 9.86
Particulars MAR 2021 (Values in Cr)
Net Income -28.35
Cash from Operations -14.57
Cash from Investing -22.54
Cash from Financing 37.66
Net change in Cash 0.53
Free Cash Flow 3.18
Particulars MAR 2020 (Values in Cr)
Net Income -28.87
Cash from Operations -35.49
Cash from Investing -10.22
Cash from Financing 28.57
Net change in Cash -17.14
Free Cash Flow -26.79
Particulars MAR 2019 (Values in Cr)
Net Income -20.12
Cash from Operations 3.89
Cash from Investing -4.31
Cash from Financing 17.32
Net change in Cash 16.90
Free Cash Flow 8.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
SANOFI INDIA LIMITED 6457.95 26.22 14.64 14872.66 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
KREBS BIOCHEMICALS & IND 84.28 0.00 -1.52 181.71 60.00 / 93.90
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 83.80
  • 26 Days 77.50
  • 10 Days 81.20
  • 50 Days 73.70
  • 12 Days 80.10
  • 100 Days 72.30
  • 20 Days 77.80
  • 200 Days 68.00
85.19
PIVOT
First Resistance 87.82
Second Resistance 92.04
Third Resistance 94.67
First Support 80.97
Second Support 78.34
Third Support 74.12
RSI 68.14
MACD 3.53
Commodity Channel Index (CCI) 133.99
ADX 60.31
Williams % R -41.88

Over 1 Month

down

17.61

Over 3 Months

down

21.88

Over 6 Months

down

5.43

Over 1 Year

down

17.51

Over 3 Years

down

-9.93

Over 5 Years

down

1.45

KREBS BIOCHEMICALS & IND Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KREBS BIOCHEMICALS & IND Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.75
Promoter Holdings
72.74
FII
0.49
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ipca Laboratories Limited Shareholding of Promoter and Promoter Group 1.0705195E7 49.65
Hemalatha Ravi Shareholding of Promoter and Promoter Group 2691524.0 12.48
Avinash Ravi Shareholding of Promoter and Promoter Group 2140272.0 9.93
Sun Pharmaceutical Industries Ltd Public Shareholding 1036943.0 4.81
Ajay Ravi Shareholding of Promoter and Promoter Group 112997.0 0.52
Dr R T Ravi Shareholding of Promoter and Promoter Group 23474.0 0.11
Aditya Ravi Shareholding of Promoter and Promoter Group 10672.0 0.05

KREBS BIOCHEMICALS & IND

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KREBS BIOCHEMICALS & IND

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KREBS BIOCHEMICALS & IND

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Krebs Biochemicals & Industries Ltd?

Answer Field

The share price of Krebs Biochemicals & Industries Ltd for NSE is ₹ 99.48 and for BSE is ₹ 99.25.

What is the Market Cap of Krebs Biochemicals & Industries Ltd?

Answer Field

The market cap of Krebs Biochemicals & Industries Ltd for NSE is ₹ 183.40 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?

Answer Field

The 52 Week High and Low of Krebs Biochemicals & Industries Ltd for NSE is ₹ 93.95 and ₹ 60.35 and for BSE is ₹ 93.90 and ₹ 60.00.

How to Buy Krebs Biochemicals & Industries Ltd share?

Answer Field

You can trade in Krebs Biochemicals & Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Krebs Biochemicals & Industries Ltd?

Answer Field

The 1 year returns on the stock has been 17.51%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader